- Adalimumab reduces extraintestinal manifestations in patients with Crohn's disease: A pooled analysis of 11 clinical studies
- Effects of adjunctive N-acetylcysteine on depressive symptoms: Modulation by baseline high-sensitivity C-reactive protein
- Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
- Pioglitazone improved insulin sensitivity and first phase insulin secretion among obese and lean people with diabetes: A multicenter clamp study
- Randomized phase II trial of autologous dendritic cell vaccines vs autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
- Effects of insulin lispro mix 25 and insulin lispro mix 50 on postprandial glucose excursion in patients with type 2 diabetes: A prospective, open-label, randomized clinical trial
- Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: Results from a phase II trial
- Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: A systematic review and meta-analysis
- Similar efficacy and safety of Basaglar and Lantus in patients with type 2 diabetes in age groups (< 65 years, ≥ 65 years): A post hoc analysis from the ELEMENT-2 Study
- Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A phase III, multicenter, randomized trial (SUMIT)
- Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
- Randomized, double-blind, placebo-controlled, multicenter phase II study of fruquintinib after two prior chemotherapy regimens in Chinese patients with advanced nonsquamous non-small-cell lung cancer
- Long-term efficacy of safinamide on Parkinson's disease chronic pain
- Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence – A Danish nationwide study
- Long-term sustainability of glycaemic achievements with second-line anti-diabetic therapies in patients with type 2 diabetes: A real-world study
Feed Sources
